117 related articles for article (PubMed ID: 8515096)
1. Parvovirus B19 infection in human immunodeficiency virus type 1-infected persons failing or intolerant to zidovudine therapy.
Naides SJ; Howard EJ; Swack NS; True CA; Stapleton JT
J Infect Dis; 1993 Jul; 168(1):101-5. PubMed ID: 8515096
[TBL] [Abstract][Full Text] [Related]
2. Infection due to parvovirus B19 in patients infected with human immunodeficiency virus.
Chernak E; Dubin G; Henry D; Naides SJ; Hodinka RL; MacGregor RR; Friedman HM
Clin Infect Dis; 1995 Jan; 20(1):170-3. PubMed ID: 7727646
[TBL] [Abstract][Full Text] [Related]
3. Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs.
Grosse-Bley A; Eis-Hübinger AM; Kaiser R; Oldenburg J; Brackmann HH; Schwarz TF; Schneweis KE
Thromb Haemost; 1994 Oct; 72(4):503-7. PubMed ID: 7878623
[TBL] [Abstract][Full Text] [Related]
4. Parvovirus B19 infection in a human immunodeficiency virus-infected patient with anemia.
Lau SM; Yu WL; Chow KC; Wang JH
J Formos Med Assoc; 2000 Feb; 99(2):162-5. PubMed ID: 10770032
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virus.
van Elsacker-Neile AM; Kroon FP; van der Ende ME; Salimans MM; Spaan WJ; Kroes AC
Clin Infect Dis; 1996 Dec; 23(6):1255-60. PubMed ID: 8953068
[TBL] [Abstract][Full Text] [Related]
6. Prolonged parvovirus b19 viremia in spite of neutralizing antibodies after erythema infectiosum in pregnancy.
Dobec M; Juchler A; Flaviano A; Kaeppeli F
Gynecol Obstet Invest; 2007; 63(1):53-4. PubMed ID: 16940737
[TBL] [Abstract][Full Text] [Related]
7. Parvovirus B19 DNA detection in treatment-naïve HIV anemic patients in Lagos, Nigeria: a case control study.
Ashaka OS; Salu OB; James AB; Oyefolu AOB; Anjorin AA; Oke BO; Orenolu MR; Omilabu SA
Afr Health Sci; 2020 Mar; 20(1):219-226. PubMed ID: 33402910
[TBL] [Abstract][Full Text] [Related]
8. Parvovirus B19 infection in HIV-1 infected patients with anemia.
Gyllensten K; Sönnerborg A; Jorup-Rönström C; Halvarsson M; Yun Z
Infection; 1994; 22(5):356-8. PubMed ID: 7843816
[TBL] [Abstract][Full Text] [Related]
9. Persistent anaemia in HIV-infected individuals due to parvovirus B19 infection.
Zuckerman MA; Williams I; Bremner J; Cohen B; Miller RF
AIDS; 1994 Aug; 8(8):1191-2. PubMed ID: 7986425
[No Abstract] [Full Text] [Related]
10. Established fibromyalgia syndrome and parvovirus B19 infection.
Berg AM; Naides SJ; Simms RW
J Rheumatol; 1993 Nov; 20(11):1941-3. PubMed ID: 8308782
[TBL] [Abstract][Full Text] [Related]
11. No evidence of persistent parvovirus B19 viremia among Iranian patients with HIV after a 1-year follow-up.
Aghakhani A; Mohraz M; Azadmanesh K; Moayedi-Nia S; Kazemimanesh M; Mamishi S; Banifazl M; Ramezani A
Arch Virol; 2016 May; 161(5):1183-7. PubMed ID: 26860911
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of antibodies to parvovirus B19 in selected groups of patients and healthy individuals.
Schwarz TF; Hottenträger B; Roggendorf M
Zentralbl Bakteriol; 1992 Feb; 276(3):437-42. PubMed ID: 1576413
[TBL] [Abstract][Full Text] [Related]
13. Acute parvovirus B19 infection during anti-retroviral therapy.
Taguchi H; Takahashi T; Goto M; Nakamura T; Iwamoto A
J Infect Chemother; 2001 Jun; 7(2):110-2. PubMed ID: 11455501
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of parvovirus B19 as a cause of anemia in patients with human immunodeficiency virus infection.
Abkowitz JL; Brown KE; Wood RW; Kovach NL; Green SW; Young NS
J Infect Dis; 1997 Jul; 176(1):269-73. PubMed ID: 9207380
[TBL] [Abstract][Full Text] [Related]
15. Parvovirus B19-related anemia in HIV-infected patients.
Koduri PR
AIDS Patient Care STDS; 2000 Jan; 14(1):7-11. PubMed ID: 12240888
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin M and G immunoblots in the diagnosis of parvovirus B19 infection.
Chen MY; Lee KL; Hung CC
J Formos Med Assoc; 2000 Jan; 99(1):24-32. PubMed ID: 10743343
[TBL] [Abstract][Full Text] [Related]
17. Immune reconstitution to parvovirus B19 and resolution of anemia in a patient treated with highly active antiretroviral therapy.
Watanabe D; Taniguchi T; Otani N; Tominari S; Nishida Y; Uehira T; Shirasaka T
J Infect Chemother; 2011 Apr; 17(2):283-7. PubMed ID: 20799048
[TBL] [Abstract][Full Text] [Related]
18. Parvovirus infection in children with AIDS: high prevalence of B19-specific immunoglobulin M and G antibodies.
Nigro G; Luzi G; Fridell E; Ferrara M; Pisano P; Gattinara GC; Mezzaroma I; Söderlund M; Rasnoveanu D; Aiuti F
AIDS; 1992 Jul; 6(7):679-84. PubMed ID: 1503687
[TBL] [Abstract][Full Text] [Related]
19. [Parvovirus B19 infection: the general aspects and gestational problems].
Di Stefano L; Carta G; Barnabei R; Tomei E; Toro G; Moscarini M
Minerva Ginecol; 1995 Apr; 47(4):121-5. PubMed ID: 7644092
[TBL] [Abstract][Full Text] [Related]
20. [Seroprevalence of human parvovirus B19 in children with fever and rash in the North of Tunisia].
Bouafsoun A; Hannachi N; Smaoui H; Boubaker SH; Kazdaghli K; Laabidi D; Boukadida J; Kechrid A
Bull Soc Pathol Exot; 2016 Aug; 109(3):165-71. PubMed ID: 27385036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]